Amarin | Ativos



Assets Alterar Data
AbbVie USD 135.16B 8.26B 2024-12
Alnylam Pharmaceuticals USD 4.24B 34.94M 2024-12
Amarin USD 750.62M 49.24M 2024-09
AstraZeneca USD 104.04B 887M 2024-12
DBV Technologies USD 65.7M 27.36M 2024-12
GlaxoSmithKline GBP 59.46B 1.41B 2024-12
Halozyme Therapeutics USD 2.06B 54.55M 2024-12
Ionis Pharmaceuticals USD 3B 77.42M 2024-12
Neurocrine Biosciences USD 3.72B 183.7M 2024-12
Novartis USD 102.25B 1.28B 2024-12



Amarin Ativos - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Apr 2025.